Clinical Utility of Circulating Tumor Cells in the Early Detection of Lung Cancer in Patients with a Solitary Pulmonary Nodule. (September 2021)

• Record Type: Journal Article
• Authors: Zhong, Manhua; Zhang, Yi; Pan, Zuguang; Wang, Wei; Zhang, Yuxin; Weng, Yuqing; Huang, Haile; He, Yanju; Liu, Ouqi
• Is Part Of: Technology in cancer research & treatment. Volume 20(2021)
• Publication Date: 2021-09
• Subjects: circulating tumor cells -- lung cancer -- solitary pulmonary nodule; Oncology -- Periodicals; Cancer -- Diagnosis -- Periodicals; Cancer -- Treatment -- Technological innovations -- Periodicals; 616.994
• DOI: 10.1177/15330338211041465
• Languages: English
• ISSNs: 1533-0346

Abstract

Objective: Lung cancer is the most common cancer and can appear as a solitary pulmonary nodule. Early detection of lung cancer in this patient population would be beneficial for the disease management. In this study, the potential application of circulating tumor cells (CTCs) on early detection of lung cancer in this population was investigated.Methods: The number of CTCs in bronchoalveolar lavage fluid and serum levels of tumor-related markers, cancer antigen 125 (CA125), carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) were measured in patients with a solitary pulmonary nodule. The association between CTCs and lung cancer was examined. The diagnosis performances of CTCs and selected tumor-related markers were compared.Results: The CTC positivity was significantly associated with lung cancer ( P = .009). The sensitivity of CTCs and CA125, CEA, NSE, and CA125/CEA/NSE was 75%, 5.6%, 0%, 25%, and 33%, respectively. The sensitivity of CTCs was improved from 75% to 83% by the combination with CA125 or NSE.Conclusion: CTCs may be helpful for the early detection of lung cancer in patients with a solitary pulmonary nodule.